GGrantIndex
Sort

261,768 grants matching gene therapy

STAT3 variants as a rheostat of immune tolerance

$1,765,357
Mark S Anderson · University Of California, San Francisco · P01 · FY2024 · AI

Dana-Farber/Harvard Cancer Center ET-CTN with Phase I Emphasis

$1,765,337
Geoffrey I Shapiro · Dana-Farber Cancer Inst · UM1 · FY2016 · CA

1/2: AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED)

$1,765,234
Fernando D Martinez · University Of Arizona · UH3 · FY2022 · HL

Repurposing an EU Therapeutic for Hemoglobinopathies

$1,765,116
Sharie Haugabook · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR

Development of Malaria Transmission-Blocking Drugs

$1,765,116
Philip Sanderson · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR

BMP Inhibitors to Treat Fibrodysplasia Ossificans Progressiva

$1,765,116
Philip Sanderson · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR

Cyclodextrin for Niemann-Pick Type C1 Disease

$1,765,116
Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR

A system approach to targeting innate immunity in AD

$1,765,056
Todd E. Golde · University Of Florida · U01 · FY2017 · AG

Washington University Molecular Imaging Center

$1,765,050
David R Piwnica-Worms · Washington University · P50 · FY2011 · CA

TIM family of genes: Role in T cell immunity and tolerance

$1,764,907
Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2016 · AI

COngenital Diarrhea and Enteropathy (PediCODE) Consortium and BioRepository

$1,764,851
Martin G Martin · University Of California Los Angeles · RC2 · FY2020 · DK

Discovery of genes required for expression or activity of fusion oncogenes

$1,764,834
Natasha Caplen · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Comparative genomic analysis of bacteria species

$1,764,774
Xiaofang Jiang · National Library Of Medicine · ZIA · FY2024 · LM

MicroRNA as a Novel Therapeutic Target for Pain in Sickle Cell Disease

$1,764,145
Ying He · Midwestern University · RF1 · FY2025 · NS

UCLA Center for AIDS Research (CFAR)

$1,764,129
Irvin S.y. Chen · University Of California Los Angeles · P30 · FY2006 · AI

Translational Approaches to Develop Drug Therapy for Diarrhea

$1,764,114
Mark Donowitz · Johns Hopkins University · R24 · FY2016 · DK

Translational Approaches to Develop Drug Therapy for Diarrhea

$1,764,114
Mark Donowitz · Johns Hopkins University · R24 · FY2017 · DK

Translational Approaches to Develop Drug Therapy for Diarrhea

$1,764,114
Mark Donowitz · Johns Hopkins University · R24 · FY2015 · DK

NK cells, their receptors and cancer therapy

$1,764,019
Jeffrey S Miller · University Of Minnesota · P01 · FY2021 · CA

REGULATION OF ANGIOGENESIS

$1,763,726
Children'S Hospital Boston · P01 · FY2001 · CA

Molecular Genetics Of Adrenocortical Tumors And Related Disorders

$1,763,630
Constantine A. Stratakis · Child Health And Human Development · Z01 · FY2007 · HD

Phase 1 study of oral epigallocatechin-3-gallate (EGCG) in IPF patients

$1,763,207
Fernando J Martinez · Univ Of Massachusetts Med Sch Worcester · R33 · FY2025 · HL

Pathogenesis and Treatment of HIV Infection

$1,763,103
H. Clifford Lane · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

Systems Analysis of Epigenomic Architecture in Cancer Progression

$1,763,095
Tim H.-M. Huang · University Of Texas Hlth Science Center · U54 · FY2021 · CA

Anesthetic-Induced Cardiac Preconditioning

$1,762,868
Zeljko J. Bosnjak · Medical College Of Wisconsin · P01 · FY2012 · GM